AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06227455 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Maxillary alveolar ridge augmentation
Description: The surgical procedure involves careful flap reflection, autogenous graft harvesting, and placement and fixation of the barriers over mixture of Autogenous graft and xenograft particles.
Study NCT06201416 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SBT777101
Description: Experimental treatment
Study NCT05625269 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education
Description: The first session of the individual training will be held for the patients in the intervention group on the first day of the service hospitalization, covering the issues related to the procedure and the hospital process. Afterwards, the second session of individual education will be held the day before discharge on issues related to the patient's home care, such as treatment site care, nutrition, exercise, medication and symptom management. In addition to the patients, their families will also participate in the training sessions. The training will be given face-to-face in a quiet environment to increase intelligibility in patients' rooms. The patients will be given a booklet and magnet prepared by the researcher in addition to the oral explanation.
Study NCT05384587 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: asciminib
Description: Supplied in 40 mg and 100 mg tablets for oral use to be taken daily. Dose may be increased at 6 and 12 months based on molecular response with BCR-ABL1 Polymerase Chain Reaction testing.
Study NCT05397808 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pilates Training
Description: The group that received pilates training.
Study NCT05397808 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: breathing and relaxation exercises
Description: The group who received breathing and relaxation exercises with a home program.
Study NCT05910931 — intervention group
Intervention type: DRUG
Intervention: ICG angiography
Description: * A first injection with the patient asleep before starting the intervention to visualize the vascular anatomy of each patient and assess the pedicles and incisions.~* A second bolus after breast resection to assess the viability of skin flaps and glandular pedicles.~* A third injection to obtain an angiography after implant placement and wound closure.~For angiography, the SPY System with the SPY-Q software will be used.
Study NCT05051397 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HYPERCAPNIA
Description: Controlled moderate hypercapnia PaCO2 50mmHg under general anesthesia with mechanical ventilation
Study NCT06390982 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: 130 mg/m2 IV on Day 1 of each 21-day cycle in CAPOX regimen
Study NCT05051397 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: NORMOCAPNIA
Description: Controlled normocapnia PaCO2 40mmHg under general anesthesia with mechanical ventilation
Study NCT05013190 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: This is a non-interventional study.
Study NCT06610370 — intervention group
Intervention type: OTHER
Intervention: Group 1
Description: 95 children with spastic cerebral palsy were included. Gross Motor Function Measure-88 (GMFM-88) and Gross Motor Function Classification System (GMFCS) were applied to the cases before and after the Selective Dorsal Rhizotomy (SDR) surgery.
Study NCT04428164 — intervention group
Intervention type: OTHER
Intervention: The Richards-Campbell Sleep Questionnaire (R-CSQ)
Description: Tool developed to assess patient satisfaction and comfort in the hospital setting.~The R-CSQ is a scale used to measure different aspects of sleep quality. This scale allows the patient to rate their quality and amount of sleep on a scale of 0-100. The R-CSQ allows the patient to rate six different components of their sleep, including sleep depth, sleep latency, awakenings, returning to sleep, sleep quality, and noise.
Study NCT04428164 — intervention group
Intervention type: OTHER
Intervention: Revised American Pain Society Outcome Questionnaire (APS-POQ-R)
Description: The APS-POQ-R can be utilized to measure perceived levels of pain in patients. The APS-POQ-R scale is a validated scale that is used in the hospital setting with reliable and consistent results. This scale measures five aspects of a patient's perception and experiences with pain and a sixth aspect including nonpharmacological interventions.
Study NCT06615583 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Surgical device
Description: The C-REX device consists of an invasive surgical part, including two anastomotic rings, and surgical instruments for assisting the placement of the anastomotic ring to intestine. The rings are loosen from the inside of the intestinal wall and expelled with faeces per rectum once the anastomosis is healed in approximately ten days.
Study NCT06615180 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Transcultural Nursing Course (new curriculum)
Description: Multinational Collaboration: Developed with input from institutions across five countries, ensuring a broad, international perspective on transcultural nursing.~Comprehensive Theoretical Framework: Integrates multiple cultural competence models (Purnell, Campinha-Bacote, Papadopoulos) with Leininger's Culture Care Theory, offering a thorough approach.~Extensive Practical Training: Includes 17 hours of hands-on experience, featuring hospital visits and interactions with healthcare professionals.~Interactive Learning Methods: Combines role-playing, reflective essays, and cultural activities (e.g., traditional clothing, dances) for dynamic, multimodal education.~Peer Education: Incorporates peer education and evaluation, enhancing collaborative learning and critical thinking.~Standardized Materials: Educational materials and teaching methods are standardized across institutions to ensure consistency and quality in instruction.
Study NCT06615466 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Partial Breast Irradiation
Description: 26Gy/5.2Gy/5f
Study NCT06613594 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physical therapy
Description: Patients will receive hot pack, Broom stick ROM exercises, Codman and strengthening exercises. A total of 10 sessions, 5 sessions per week for 2 consecutive weeks.
Study NCT06613594 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy
Description: Patients will receive hot pack, Broom stick ROM exercises, Codman and strengthening exercises. A total of 10 sessions, 5 sessions per week for 2 consecutive weeks.
Study NCT06613594 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kaltenborn traction mobilization
Description: kaltenborn direction non specific traction mobilization for (1 minute), 3 sets of 10 reps with 1 minute rest in between will be given.
Study NCT06613594 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kaltenborn translatoric glides
Description: Kaltenborn direction specific linear tranlatoric glides, rhtymic 5reps of each glide, such anterior glide for extension and external rotation, caudal glide for abduction,post glide for flexion and internal roation,these3 sets of painless glides will performed with 10 reps,rest of 1 minutes between these sets.
Study NCT06282770 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser Diode Brace
Description: The device is a brace with laser diodes. The braces light up and the red light has therapeutic abilities.
Study NCT06282770 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Laser Diode Brace
Description: The Sham brace has no therapeutic ability and will act as a placebo.
Study NCT05737563 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PD-1 Inhibitors
Description: Teripulimab 240mg, injection or Carrelizumab 200mg, injection, every 3 weeks.
Study NCT05737563 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Irinotecan
Description: Irinotecan: 200mg/m2, injection (For patients who are confirmed to be homozygous for UGT1A1\*6 or UGT1A1\*28 or UGT1A1\*6 and UGT1A1\*28 at the same time, the starting dose of CPT-11 is 150 mg/m2).
Study NCT05737563 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan
Description: Irinotecan: 200mg/m2, injection (For patients who are confirmed to be homozygous for UGT1A1\*6 or UGT1A1\*28 or UGT1A1\*6 and UGT1A1\*28 at the same time, the starting dose of CPT-11 is 150 mg/m2).
Study NCT05737563 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Capecitabine tablets
Description: Capecitabine: 1600 mg/m2/d, oral, 2 weeks on and 1 week off.
Study NCT05737563 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine tablets
Description: Capecitabine: 1600 mg/m2/d, oral, 2 weeks on and 1 week off.
Study NCT05613010 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mHealth Messaging Intervention Group
Description: Participants will receive an electronic pill box; the research team will instruct participants on how to use this device. Participants will be asked to use the electronic pill box for their prescribed medicines for the duration of the study (up to 16 months). During the 12-week micro-randomized trial, participants will be randomized within person to receive (1) adherence support text messages or (2) no text message after each missed dose, and (1) praise text message or (2) no text message after each on time dose. Dose timing will be determined based on participant report of when they typically take their tacrolimus or sirolimus medicine.
Study NCT06376994 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Air cleaner
Description: The intervention is two active air cleaners with high efficiency particulate air (HEPA) filters which remove PM, as well as activated carbon filters to remove NO2 (and other trace gases). These will be run for a year in a participant's house.
Study NCT06376994 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham air cleaner
Description: The sham intervention is two sham air cleaners that have the internal HEPA and carbon filters removed, but which will run normally, including similar noise, airflow, and overall appearance compared to active air cleaners, thus blinding participants to filter status. These will be run for a year in a participant's house.
Study NCT06390982 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: 825 mg/m2 orally twice daily (bid) 5 days/week during radiotherapy.
Study NCT06554626 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Glucocorticoids
Study NCT06554626 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Blinatumomab
Description: Bi-specific anti CD19/CD3 antibody
Study NCT06554626 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: BCL-2 inhibotor
Study NCT06554626 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inotuzumab ozogamicin
Description: a humanized monoclonal antibody-drug conjugate targeting CD22
Study NCT06554626 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: antifolate antineoplastic drug
Study NCT06554626 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegaspargase
Description: antitumor drug
Study NCT06554626 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Pyrimidine, antimetabolites
Study NCT06156540 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: virtual reality glasses
Description: Using virtual reality glasses, caregivers in the experimental group were shown 360-degree VR relaxing videos.
Study NCT04824183 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music intervention
Description: Three WhatsApp sessions will be delivered before the surgery. In the first session, participants will describe their experience with the diagnosis of breast cancer and acceptance. In the second session, participants will be educated on anxiety before their surgery, how anxiety is being managed in the hospital and self-care strategies for anxiety like MI, how to report preoperative anxiety. The third session will include postoperative pain education. The pain education will include information about the type of pain to expect after surgery, medications, pain reporting and MI for pain management. Telephone session; on the day of surgery and at 24 and 48 hours after surgery, a reminder will be sent to the participants by WhatsApp group chat. Face-to-face; MI delivery will involve the delivery of the MP3 to participants and monitoring of their use for 30 minutes both on the day of surgery and 24 and 48 hours after surgery.
Study NCT05686720 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SZ011 CAR-NK
Description: In the escalation study, the minimum initial dose was 5.0×10\^6 cells, then increased to 5.0×10\^7 and 2.0×10\^8 cells. The infusion is given every 2 weeks.
Study NCT03328455 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Inhibitory control training
Description: Cognitive training is inhibitory task-related.
Study NCT03328455 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Knowledge-based training
Description: Training is not inhibitory task-related.
Study NCT05926245 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Glutaryl Solution
Description: Glutathione, ascorbic acid, cyclodextrin, potassium sorbate and radish root extracts
Study NCT06207851 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcatheter Arterial Micro-Embolization
Description: Participants will undergo TAME with Nexsphere-F.
Study NCT05926245 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Solution
Description: Empty nanoparticles
Study NCT05317689 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Psilocin
Description: 17.5mg oral psilocin with psychological support and physiological monitoring
Study NCT05317689 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Psilocybin
Description: 25mg oral psilocybin with psychological support and physiological monitoring
Study NCT05317689 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sublingual Psilocin
Description: 2.18mg - 4.36mg sublingual psilocin with psychological support and physiological monitoring
Study NCT06325904 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Uniportal VATS
Description: * single port video-assisted thoracoscopic surgery in the 5th intercostal space~* performed under general anesthesia.~* pleural fluid/pus was drained~* pleural adhesions was removed
Study NCT06325904 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Tube thoracostomy
Description: * Chest tube is inserted in 5th mid-axillary line~* performed under local anaesthesia
Study NCT05217927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rimegepant 75mg daily dosing
Description: Daily
Study NCT05217927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rimegepant 75mg every other day dosing
Description: Every other day
Study NCT05217927 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo comparator dosing
Description: Placebo comparator
Study NCT06210282 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Focused lung ultrasound (FLUS)
Description: We will use a 14-zone scanning approach. Each hemithorax is divided into anterior, lateral, and posterior surfaces. The anterior and lateral surfaces on each hemithorax are divided into an upper and lower quadrant. The posterior surfaces on each hemithorax are divided into an upper, middle, and lower quadrant. Each quadrant represents a scanning zone. Each scanning zone should be assessed using FLUS. The participating general practitioners use point-of-care ultrasound on a weekly basis before trial commencement and will use the ultrasonography device already available to them.
Study NCT06210282 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Participants assigned to the control group will receive the GP's usual care of adults (≥ 18 years) presenting with symptoms of an acute LRTI where the GP suspects CAP. Usual care will be used as a pragmatic comparator to reflect the current standard examinations and care of these patients in general practices in Denmark. Usual care is recommended to follow applicable guidelines from the Danish Society of General Practitioners (DSAM) and Lægehåndbogen \[The Doctor's Handbook\].
Study NCT06210282 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual Care
Description: Participants assigned to the control group will receive the GP's usual care of adults (≥ 18 years) presenting with symptoms of an acute LRTI where the GP suspects CAP. Usual care will be used as a pragmatic comparator to reflect the current standard examinations and care of these patients in general practices in Denmark. Usual care is recommended to follow applicable guidelines from the Danish Society of General Practitioners (DSAM) and Lægehåndbogen \[The Doctor's Handbook\].
Study NCT05540106 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nature Coloring Packet
Description: Coloring packet containing nature scenes
Study NCT05540106 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Geometric Shape Coloring Packet
Description: Coloring packet containing geometric shapes
Study NCT05370989 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Technology-Based Parent School Program
Description: The program will be continued for 10 weeks in the intervention group and will be included five web-based modules, five online group interactions after each module, and consultation throughout the program and the follow-up period.
Study NCT05370989 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ongoing treatment
Description: Health service of the control group will ongoing.
Study NCT05370989 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ongoing treatment
Description: Health service of the control group will ongoing.
Study NCT05540106 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Activity Book
Description: Pages containing word searches, connect the dots, etc.
Study NCT05540106 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Blank Paper and Pencil
Description: Blank sheets of paper and a pencil.
Study NCT05948930 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Progressive aerobic exercise
Description: Progressive aerobic exercise
Study NCT05948930 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive cognitive training
Description: Adaptive cognitive training
Study NCT05948930 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Combined
Description: Combine adaptive cognitive and progressive aerobic exercise training
Study NCT04715724 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Positioning and Attachment video-based simulation (telesimulation)
Description: Participants will teach a standardized patient actor (SP) to position and attach the baby doll at the breast of the Lactation Simulation Model in a video-based simulation (telesimulation)
Study NCT04715724 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Positioning and Attachment video-based simulation (telesimulation)
Description: Participants will teach a standardized patient actor (SP) to position and attach the baby doll at the breast of the Lactation Simulation Model in a video-based simulation (telesimulation)
Study NCT05140993 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: extended emotional and orientation support
Description: extended emotional and orientation support
Study NCT02145910 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vemurafenib
Description: Given PO
Study NCT04946825 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy patch
Description: The nicotine patch is attached to the participant's skin and provides a slight constant stream of nicotine. The smaller dose is meant to reduce nicotine dependence.
Study NCT04946825 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy lozenge
Description: The nicotine lozenge contains small amounts of nicotine, which a participant slowly dissolves in their mouth. Like the patch, the smaller dose is meant to reduce nicotine dependence.
Study NCT02145910 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Whole-brain radiation therapy (WBRT)
Description: Undergo WBRT
Study NCT02145910 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiosurgery (SRS)
Description: Undergo SRS
Study NCT06058780 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Implantable Collamer Lens (ICL)
Description: Phakic intraocular lenses (pIOL) have proven to be a great alternative to corneal refractive surgery in certain situations. They offer several advantages over corneal techniques, such as being suitable for high myopes and causing relatively fewer higher-order aberrations
Study NCT06058780 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Implantable Intraocular Lens (IPCL)
Description: The IPCL offers a distinct economic advantage as the cost of the IPCL implant is only 2. times that of the ICL implant. Moreover, the IPCL can correct higher degrees of myopia, up to -30. D, compared to the maximum correction of -18. D provided by the ICL.
Study NCT06349486 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: vonoprazan, amoxicillin, tripotassium dicitrate bismuthate
Description: bismuth-amoxicillin-vonoprazan triple therapy
Study NCT06349486 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: vonoprazan, amoxicillin
Description: vonoprazan-amoxicillin dual therapy
Study NCT06349486 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: rabeprazole, amoxicillin, clarithromycin
Description: proton pump inhibitor-based standard triple therapy